Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

BACKGROUND/AIMS: To date, there is no prospective study that specifically investigated the efficacy of infliximab in intestinal Behçet’s disease (BD). This study evaluated the efficacy of infliximab in patients with moderate-to-severe active intestinal BD that are refractory to conventional therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Jae Hee, Kim, Hyun-Soo, Han, Dong Soo, Kim, Sung Kook, Shin, Sung Jae, Kim, Joo Sung, Ye, Byong Duk, Song, Geun Am, Lee, YoungJa, Kim, Youngdoe, Lee, Yoosun, Kim, Won Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502498/
https://www.ncbi.nlm.nih.gov/pubmed/36578194
http://dx.doi.org/10.5009/gnl220278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502498/
https://www.ncbi.nlm.nih.gov/pubmed/36578194
http://dx.doi.org/10.5009/gnl220278

Ejemplares similares